# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-25-111760
Filing Date
2025-11-18
Accepted
2025-11-18 06:44:14
Documents
19
Period of Report
2026-01-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROXY STATEMENT | ea0263416-03.htm iXBRL | DEF 14A | 1319771
2 | GRAPHIC | tjoycemason_sig.jpg | GRAPHIC | 30168
3 | GRAPHIC | tproxy_001.jpg | GRAPHIC | 1095230
4 | GRAPHIC | tproxy_002.jpg | GRAPHIC | 1324524
5 | GRAPHIC | tproxy_003.jpg | GRAPHIC | 1143035
| Complete submission text file | 0001213900-25-111760.txt |  | 10582487

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | rfl-20251118.xsd | EX-101.SCH | 9892
7 | XBRL DEFINITION FILE | rfl-20251118_def.xml | EX-101.DEF | 2763
8 | XBRL LABEL FILE | rfl-20251118_lab.xml | EX-101.LAB | 34739
9 | XBRL PRESENTATION FILE | rfl-20251118_pre.xml | EX-101.PRE | 5450
21 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0263416-03_htm.xml | XML | 247879

Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 001-38411 | Film No.: 251492768
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)